167 related articles for article (PubMed ID: 3626303)
1. Aluminium-related osteomalacia: response to reverse osmosis water treatment.
Smith GD; Winney RJ; McLean A; Robson JS
Kidney Int; 1987 Jul; 32(1):96-101. PubMed ID: 3626303
[TBL] [Abstract][Full Text] [Related]
2. Dialysate aluminium concentration and renal bone disease.
Walker GS; Aaron JE; Peacock M; Robinson PJ; Davison AM
Kidney Int; 1982 Feb; 21(2):411-5. PubMed ID: 7070002
[TBL] [Abstract][Full Text] [Related]
3. Histological and electron microprobe studies of mineralisation in aluminium-related osteomalacia.
Boyce BF; Byars J; McWilliams S; Mocan MZ; Elder HY; Boyle IT; Junor BJ
J Clin Pathol; 1992 Jun; 45(6):502-8. PubMed ID: 1624597
[TBL] [Abstract][Full Text] [Related]
4. Aluminium-induced osteomalacia in severe chronic renal failure (SCRF).
Visser WJ; Van de Vyver FL
Clin Nephrol; 1985; 24 Suppl 1():S30-6. PubMed ID: 3915958
[TBL] [Abstract][Full Text] [Related]
5. Osteomalacic dialysis osteodystrophy: Evidence for a water-borne aetiological agent, probably aluminium.
Ward MK; Feest TG; Ellis HA; Parkinson IS; Kerr DN
Lancet; 1978 Apr; 1(8069):841-5. PubMed ID: 76795
[TBL] [Abstract][Full Text] [Related]
6. Hypercalcaemic osteomalacia due to aluminium toxicity.
Boyce BF; Fell GS; Elder HY; Junor BJ; Elliot HL; Beastall G; Fogelman I; Boyle IT
Lancet; 1982 Nov; 2(8306):1009-13. PubMed ID: 6127501
[TBL] [Abstract][Full Text] [Related]
7. Water supply aluminium concentration, dialysis dementia, and effect of reverse-osmosis water treatment.
Davison AM; Walker GS; Oli H; Lewins AM
Lancet; 1982 Oct; 2(8302):785-7. PubMed ID: 6126664
[TBL] [Abstract][Full Text] [Related]
8. Healing of fracturing-bone disease occurring in patients on dialysis. A prospective study.
Milne FJ; Hudson GA; Meyers AM; Baily P; Barmeir E; Dubowitz B; Reis P
S Afr Med J; 1982 Jun; 61(25):955-9. PubMed ID: 7089762
[TBL] [Abstract][Full Text] [Related]
9. The pathogenesis of renal osteodystrophy: role of vitamin D, aluminium, parathyroid hormone, calcium and phosphorus.
Dunstan CR; Hills E; Norman AW; Bishop JE; Mayer E; Wong SY; Johnson JR; George CR; Collett P; Kalowski S
Q J Med; 1985 May; 55(217):127-44. PubMed ID: 4001311
[TBL] [Abstract][Full Text] [Related]
10. [The role of aluminum in the development of osteomalacia in patients on chronic hemodialysis].
Adamiec R; Uzar J
Pol Arch Med Wewn; 1988 Jan; 79(1):3-12. PubMed ID: 3275167
[TBL] [Abstract][Full Text] [Related]
11. Changes in bone histoquantitative parameters and histochemical staining reactions for aluminium in a group of patients with chronic renal failure following a reduction in the aluminium concentration of the haemodialysis fluid.
McClure J; Fazzalari NL; Fassett RG; Pugsley PG
J Clin Pathol; 1984 Jul; 37(7):743-7. PubMed ID: 6747011
[TBL] [Abstract][Full Text] [Related]
12. Aluminum-related osteomalacia: clinical and histological improvement following treatment with desferrioxamine (DFO).
Rapoport J; Chaimovitz C; Abulfil A; Mostovlavsky M; Gazit D; Bab I
Isr J Med Sci; 1987 Dec; 23(12):1242-6. PubMed ID: 3440748
[TBL] [Abstract][Full Text] [Related]
13. Acute epidemic aluminium osteomalacia secondary to water supply contamination.
O'Brien AA; Moore DP; Keogh JA
Ir J Med Sci; 1990 Mar; 159(3):71-3. PubMed ID: 2361822
[TBL] [Abstract][Full Text] [Related]
14. Can low-dosage aluminium hydroxide control the plasma phosphate without bone toxicity?
Jenkins DA; Gouldesbrough D; Smith GD; Cowie JF; Winney RJ
Nephrol Dial Transplant; 1989; 4(1):51-6. PubMed ID: 2494599
[TBL] [Abstract][Full Text] [Related]
15. [Osteomalacia as a result of aluminum poisoning during chronic hemodialysis].
Cournot-Witmer G; Gagnadoux MF; Lebon P; Broyer M; Balsan S
Arch Fr Pediatr; 1982 Dec; 39 Suppl 2():749-54. PubMed ID: 6762177
[TBL] [Abstract][Full Text] [Related]
16. Bone aluminum deposition in maintenance dialysis patients treated with aluminium-free dialysate: role of aluminium hydroxide consumption.
Heaf JG; Pødenphant J; Andersen JR
Nephron; 1986; 42(3):210-6. PubMed ID: 3945361
[TBL] [Abstract][Full Text] [Related]
17. The role of aluminium in experimental osteomalacia. Preliminary results: Aluminium content and bone mineralization.
Costantini S; Bonucci E; Mocetti P; Ballanti P; Giordano R; Vernillo I; Ioppolo A; Mantovani A; Stasolla D
Ann Ist Super Sanita; 1986; 22(2):689-95. PubMed ID: 3752831
[No Abstract] [Full Text] [Related]
18. Deferoxamine-induced bone changes in haemodialysis patients: a histomorphometric study.
Charhon SA; Chavassieux P; Boivin G; Parisien M; Chapuy MC; Traeger J; Meunier PJ
Clin Sci (Lond); 1987 Aug; 73(2):227-34. PubMed ID: 3652627
[TBL] [Abstract][Full Text] [Related]
19. Histochemical demonstration of iron but not aluminum in a case of dialysis-associated osteomalacia.
Phelps KR; Vigorita VJ; Bansal M; Einhorn TA
Am J Med; 1988 Apr; 84(4):775-80. PubMed ID: 3041812
[TBL] [Abstract][Full Text] [Related]
20. Aluminium osteomalacia in chronic renal failure patients neither on dialysis nor taking aluminium containing phosphate binders.
O'Brien AA; Moore DP; Keogh JA
Ir J Med Sci; 1990 Mar; 159(3):74-6. PubMed ID: 2361823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
